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Abstract
Aims and objectives—To determine whether a single-item self-report medication adherence
question predicts hospitalization and death in patients with heart failure (HF).
Background—Poor medication adherence is associated with increased morbidity and mortality.
Having a simple means of identifying sub-optimal medication adherence could help identify at-
risk patients for interventions.
Design—We performed a prospective cohort study in 592 participants with HF within a 4-site
randomized trial.
Methods—Self-report medication adherence was assessed at baseline using a single-item
question: “Over the past 7 days, how many times did you miss a dose of any of your heart
medication?” Participants who reported no missing doses were defined as fully adherent; those
missing ≥ 1 dose were considered less than fully adherent. The primary outcome was combined
all-cause hospitalization or death over 1 year; the secondary endpoint was HF hospitalization.
Outcomes were assessed with blinded chart reviews and HF outcomes were determined by a
blinded adjudication committee. We used negative binomial regression to examine the relationship
between medication adherence and outcomes.
Results—Participants were 52% male, mean age was 61 years, and 31% were NYHA III/IV at
enrollment; 72% of participants reported full adherence to their heart medicine at baseline.
Participants with full medication adherence had a lower rate of all-cause hospitalization and death
(0.71 events/year) compared with those with any non-adherence (0.86 events/year): adjusted for
site incidence rate ratio (IRR) was 0.83, fully adjusted IRR 0.68. IRRs were similar for HF
hospitalizations.
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Conclusion—A single medication adherence question at baseline predicts hospitalization and
death over 1 year in HF patients.
Relevance to clinical practice—Medication adherence is associated with all-cause and HF-
related hospitalization and death in HF. It is important for clinicians to assess patients’ medication
adherence on a regular basis at their clinical follow-ups.
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Introduction
Heart failure (HF) is a chronic condition manifested in high morbidity and mortality and
poor quality of life (Go et al., 2013; Riegel et al., 2009). Heart failure is characterized by
episodes of instability that commonly require hospitalization (Opasich et al., 1996).
Rehospitalization rates in patients with HF are high (Go, et al., 2013; Lloyd-Jones et al.,
2010; Stewart et al., 2001): with 50% of patients readmitted within six months of discharge
from a hospitalization for exacerbation of HF (Go, et al., 2013; Hamner & Ellison, 2005;
Krumholz et al., 2000; Smith et al., 2000).
Patients with HF need to adhere to their prescribed medications to prevent and control
symptoms and decrease the need for hospital admission (Hauptman, 2008; Hodges, 2009).
However, medication adherence rates in patients with HF are sub-optimal, about 40–60%
(Wu, Moser, Lennie, & Burkhart, 2008). Prior studies have shown that poor medication
adherence is associated with increased all-cause emergency department (ED) visits
(Esposito, Bagchi, Verdier, Bencio, & Kim, 2009; Murray et al., 2009), cardiovascular
(CV)-related ED visits (Hope, Wu, Tu, Young, & Murray, 2004; Murray et al., 2007), all-
cause hospitalizations (Esposito, et al., 2009; Li, Morrow-Howell, & Proctor, 2004; Murray,
et al., 2009; Murray, et al., 2007; Sun, Ye, Lee, Dupclay, & Plauschinat, 2008), CV-related
hospitalizations (Chui et al., 2003; Murray, et al., 2007), HF hospitalizations (Ambardekar et
al., 2009; Annema, Luttik, & Jaarsma, 2009; Chui, et al., 2003; Cole, Norman, Weatherby,
& Walker, 2006; Murray, et al., 2007), mortality (Granger et al., 2005; Miura et al., 2001;
Wu, Moser, Chung, & Lennie, 2008), longer length of stay in hospital (Esposito, et al.,
2009; Miura, et al., 2001), high healthcare cost (Cole, et al., 2006; Esposito, et al., 2009;
Sun, et al., 2008), and poor health status (Morgan et al., 2006) in patients with HF.
Interventions to improve medication adherence can reduce clinical events and reduce costs
(Murray, et al., 2007).
There are many methods to measure the extent of medication adherence: patient self-report;
estimates by physicians, other health care providers, and/or family members; pill counts;
pharmacy refill data; biological assays of blood, urine or saliva; and electronic pill caps such
as the Medication Event Monitoring System (MEMS). All current measures have strengths
and weaknesses (Wu, et al., 2008). Any measurement of medication adherence that is
complicated, expensive, intrusive, or time-consuming is not ideal in clinical settings. Having
a simple means of identifying sub-optimal adherence could help identify at-risk patients for
interventions. Accordingly, the purpose of this study was to determine whether a single-item
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This investigation was a secondary analysis of data from a prospective cohort study
conducted within a 1-year, 4-site randomized controlled trial (RCT) comparing different
levels of self-care training (single-session vs. multisession). All participants were
interviewed at baseline to collect data on demographic and clinical variables and to complete
baseline questionnaires (including single-item self-report medication adherence).
Participants randomized to the single session group received a 40-minute in-person self-care
training; those in the multisession group received the same initial training and then ongoing
phone-based support. Outcome data were collected at 6 months and 12 months through
phone interviews followed by medical record reviews.
The funding agent, National Heart, Lung, And Blood Institute had no role in the design and
conduct of the study; collection, management, analysis, and interpretation of the data; and
preparation, review, or approval of the manuscript.
Sample and Setting
Detailed eligibility criteria, recruitment methods, and data collection processes have been
published previously (Dewalt et al., 2012). In short, participants were recruited from March
2007 to December 2009 from university-affiliated General Internal Medicine and
Cardiology outpatient clinics at 4 sites: University of North Carolina at Chapel Hill;
Feinberg School of Medicine, Northwestern University; University of California, San
Francisco- San Francisco General Hospital; and Olive View-UCLA Medical Center.
Participants who had a confirmed diagnosis of chronic HF, New York Heart Association
(NYHA) class II-IV symptoms in the past 6 months, current use of a loop diuretic
medication, and no cognitive impairment were enrolled in this study.
Measurement
Medication Adherence—Medication adherence was measured by patient self-report at
baseline using a single item question that is commonly and widely used in the clinical
settings: “Over the past 7 days, how many times did you miss a dose of any of your heart
medication?” Participants who reported no missing doses were defined as fully adherent;
those missing ≥ 1 dose were considered less than fully adherent.
Outcomes—The primary end-point for this study was all-cause hospitalization and death.
The secondary end-point was HF-related hospitalization.
A detailed description of our outcome measures has been published elsewhere (DeWalt et
al., 2009; Dewalt, et al., 2012). In short, the UNC Survey Research Unit interviewed
participants by telephone at 6 and 12 months to collect data on any hospitalizations that had
occurred in the previous time period and/or any reports of death. Initial data were obtained
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by patient interview. Records were requested for the full study period from any hospitals in
which the patient reported having had a hospital admission. We obtained admission and
discharge summaries, key reports, and for deaths we also obtained death certificates when
possible. During data collection, the date and reasons for hospitalization and death were
noted. To determine whether a hospitalization was HF-related, one member of the 3-member
adjudication committee, masked to study arm assignment and adherence, reviewed the
admission and discharge summaries to determine if the hospitalization was heart failure-
related. A second reviewer examined the same data for ambiguous cases; if the first two
reviewers disagreed, a third reviewer helped resolve discrepancies (DeWalt, et al., 2009;
Dewalt, et al., 2012).
Demographic variables—Age, gender, ethnicity, income, education level, health literacy
socioeconomic status, and insurance were collected from patient interview as demographic
variables. Socioeconomic status is the participant’s subjective assessment of his or her
position in society relative to others based on wealth. Health literacy was measured using the
short Test of Functional Health Literacy in Adults (S-TOFHLA). Each participant’s literacy
level is categorized as low (0–22) or higher literacy (23–36) (Gazmararian et al., 1999). This
instrument is one of the most commonly used instruments in research. It has been validated
in several thousand patients, including patients with cardiovascular-related diseases and
other chronic diseases (Gazmararian et al., 2006; Kalichman et al., 2008).
Clinical variables—New York Heart Association (NYHA) class, systolic dysfunction
(ejection fraction < 45%), systolic and diastolic blood pressure (BP), body mass index
(BMI), creatinine level, presence of diabetes, hypertension, atrial fibrillation, previous
myocardial infarction, chronic kidney disease, smoking status, depressive symptoms, HF
medication prescriptions, and HF symptoms (Baker, Brown, Chan, Dracup, & Keeler, 2005)
were collected from patient interview and medication record review as clinical variables.
Depressive symptoms were measured using the Patient Health Questionnaire-9 (PHQ-9)
(Ackermann et al., 2005; Kroenke, Spitzer, & Williams, 2001). The PHQ-9 is a reliable
(Kroenke, et al., 2001) and valid (Ackermann, et al., 2005; Kroenke, et al., 2001) scale that
has been used to measure depressive symptoms in patients with HF (Ackermann, et al.,
2005). HF-related symptoms were measured using a 7-item Heart Failure Symptom Scale
(HFSS)(Baker, et al., 2005). The HFSS is a reliable and validated instrument to measure HF
symptoms in patients with HF (Baker, et al., 2005; Macabasco-O'Connell et al., 2011).
Knowledge and behavioral variables—We also assessed HF general knowledge, salt
knowledge, HF self-efficacy and HF self-care behaviors. HF general knowledge, salt
knowledge, and HF self-care behaviors were measured using an adapted version of the
Improving Chronic Illness Care Evaluation (ICICE) telephone survey (Baker, et al., 2005).
HF general knowledge questions included general HF knowledge such as definition of HF,
with a total score ranging 0–8, higher scores indicate greater knowledge. Salt knowledge
questions included which foods contain a lot of salt, with a total score ranging 0–10. Self-
care behaviors included weight monitoring, following a low salt diet, and exercising.
Participants’ self-efficacy was assessed using a 10-item Self-Efficacy Scale to measure their
perceived confidence in managing their HF symptoms and performing self-care behaviors
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(Macabasco-O'Connell, et al., 2011). These scales are reliable and valid instruments that
have been used to measure knowledge, self-care behaviors, and self-efficacy in patients with
HF (Baker, et al., 2005).
Procedure
Permission for the conduct of the study was obtained from the Institutional Review Board
(IRB) for all sites. Patient eligibility was confirmed by a trained research assistant. The
research assistant explained study requirements to the eligible participants and obtained
informed, written consent. All data included medication adherence, demographic, clinical,
knowledge and behavioral variables were collected by interview at baseline. Outcome data
were collected for 12 months for each participant.
Data Management and Analysis
All data analyses were performed using Stata 12 (College Station, TX); a significance level
of .05 was used throughout. Data analysis began with a descriptive examination of all
variables, including frequency distributions, percent, means, and standard deviations, as
appropriate to the level of measurement of the variables.
We initially compared differences in demographic and clinical factors between fully
adherent and less than fully adherent participants using chi-square and t-tests. We then
compared differences in the incidence rates of the primary and secondary outcomes between
adherence groups using negative binomial regression. We first examined differences
adjusted for site. Next, we repeated the models adjusting for demographics, clinical factors,
and intervention status that were statistically significantly different between groups or that
might have an impact on the outcomes from the literature (partially adjusted). Finally, we
repeated the analysis adding knowledge and behavioral factors to the model (fully adjusted).
In each multiple regression, data examination showed no problems with collinearity.
Standard errors were adjusted for clustering by site. We also examined the effect of defining
adherence using a different cutpoint (0–1 missing dose vs. >1 missing dose) as a sensitivity
analysis. We conducted two additional sensitivity analyses by including total number of HF
medications in the fully adjusted models and exploring the relationship between medication
adherence and events with a shorter follow-up period (6 months).
Results
Patient Characteristics
We approached 1842 patients for enrollment: 682 did not meet inclusion criteria and 555
refused to participate. The remaining 605 met the inclusion criteria, agreed to participate,
their physician allowed participation, and they were enrolled. 592 participants in the trial
with no missing data from medication adherence, hospitalization and death, and covariates
were included in this prospective cohort study (Table 1). The mean age was 61 ± 13 years.
Fifty-eight percent had systolic dysfunction, 52% were male, 38% were white, 39% African
American, and 16% Hispanic, and English was the preferred language for 86%. There were
51% who reported an income below $15,000/year, only 21% reported an income above
$40,000, and 63% had adequate health literacy level. Compared to the general HF
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population (Felker et al., 2004; O'Connor, Stough, Gallup, Hasselblad, & Gheorghiade,
2005; Pfeffer et al., 2003), participants in this study were younger and more likely to be
African-Americans.
Fully Medication Adherent vs. Less than Fully Adherent
429 participants (72%) reported full adherence to their heart medicine (0 missed) at baseline.
163 participants (28%) were less than fully adherent (80 with 1 missed dose, 62 with 2–3
missed doses, and 21 with 4+ missed doses). Compared to participants who were less than
fully adherent, fully adherent participants were older, were more likely to have medical
insurance, to have history of hypertension or chronic kidney disease, were less likely to be
current smoker or depressed, reported higher subjective socioeconomic status, had lower
diastolic BP, scored higher on self-efficacy, and performed more self-care behaviors (Table
1). No other demographic and clinical characteristic differed between these two groups.
Medication Adherence and Hospitalization and Death
Table 2 shows differences in clinical outcomes by medication adherence. For all-cause
hospitalization and death, participants who reported full medication adherence had a lower
rate of events (0.71 events / year) compared with those with any non-adherence (0.86 event /
year). For HF-related hospitalization, participants with full medication adherence also had a
lower rate of events (0.28 event / year) compared with their less than fully adherent
counterparts (0.33 event / year). There were no differences in all-cause hospitalization/death
or HF hospitalization between participants who reported full medication adherence or less
than full adherence (p=0.99 and 0.92, respectively). After adjusting for site, for participants
who were fully adherent had fewer events of all-cause hospitalization or death and HF
hospitalization: the incidence rate ratio (IRR) was 0.83 (95% CI: 0.69-1.00, p = 0.05) for all-
cause hospitalization or death, and 0.84 (95% CI: 0.77-0.92, p < 0.001) for HF
hospitalization. When adding demographics, clinical factors, and intervention status to the
model, the partially adjusted IRR for all-cause hospitalization and death = 0.71 (95% CI:
0.58-0.88, p < 0.001) and for HF hospitalization = 0.71 (95% CI: 0.56-0.89, p < 0.001).
When we repeated the analysis adding knowledge and behavioral factors to the model, the
fully adjusted IRR for all-cause hospitalization and death = 0.68 (95% CI: 0.53-0.86, p <
0.001) and for HF hospitalization = 0.64 (95% CI: 0.43-0.96, p = 0.03) (Table 2).
Sensitivity analysis
When full adherence was defined as 0–1 missing dose (vs. >1 dose), we found similar
results for the models in which we adjust for characteristics beyond site only. When
adjusting for site, adherent participants had an IRR of 0.68 (95% CI: 0.48-0.98, p = 0.04) for
all-cause hospitalization or death, and 0.66 (95% CI: 0.39-1.12, p = 0.13) for HF
hospitalization. In the partially adjusted model, the IRR was 0.66 (95% CI: 0.47-0.93, p =
0.02) and 0.62 (95% CI: 0.43-0.90, p = 0.01) for all-cause and HF hospitalization,
respectively. In the fully adjusted model, IRR was 0.61 (95% CI: 0.46-0.82, p < 0.001) and
0.49 (95% CI: 0.38-0.64, p < 0.001) for all-cause and HF hospitalization, respectively.
Adjusting for number of HF medications did not change the results, IRRs changed from 0.68
to 0.69 for all-cause events and from 0.64 to 0.65 for HF hospitalization. The relationship
Wu et al. Page 6






















between medication adherence and all-cause events was similar when we used a shorter
followup period for outcome assessment: the point estimate for the six month fully adjusted
all-cause model changed from 0.68 to 0.74.
Discussion
In this study, a single question on medication adherence measured at baseline predicted
hospitalization and death over 1 year in participants with HF. Fully adherent participants had
a lower rate of events compared with less than fully adherent participants before and after
adjusting for site, demographic, clinical, knowledge, and behavioral factors.
Consistent with prior investigators’ findings, participants who had higher adherence to
prescribed medications had a lower risk of events (hospitalizations, or death) compared with
those who had lower adherence (Ambardekar, et al., 2009; Annema, et al., 2009; Chin &
Goldman, 1997; Chui, et al., 2003; Cole, et al., 2006; Esposito, et al., 2009; Ghali, Kadakia,
Cooper, & Ferlinz, 1988; Granger, et al., 2005; Hope, et al., 2004; Li, et al., 2004; Miura, et
al., 2001; Murray, et al., 2009; Murray, et al., 2007; Nelson, Reid, Ryan, Willson, &
Yelland, 2006; Sokol, McGuigan, Verbrugge, & Epstein, 2005; Sun, et al., 2008). In these
studies, medication adherence was measured by self-report methods in six studies
(Ambardekar, et al., 2009; Annema, et al., 2009; Chin & Goldman, 1997; Ghali, et al., 1988;
Li, et al., 2004; Nelson, et al., 2006), by physician estimate in one study (Granger, et al.,
2005), by pharmacy refill in five studies (Cole, et al., 2006; Esposito, et al., 2009; Murray, et
al., 2009; Sokol, et al., 2005; Sun, et al., 2008), by MEMS in four studies (Chui, et al., 2003;
Hope, et al., 2004; Murray, et al., 2007; Wu, et al., 2008), and by serum digoxin levels in
one study (Miura, et al., 2001). The finding of these prior studies and our study emphasize
the importance of medication adherence on health outcomes in HF.
It is important to use reliable, valid, and accurate methods to measure medication adherence.
In research settings, investigators tend to choose objective measures, such as MEMS, to
measure medication adherence. Self-reported adherence, a subjective method, has often been
criticized because of the potential for sub-optimal accuracy due to recall bias, social
desirability, and may lead to over-estimated medication adherence. However, in clinical
settings, it is important to find a way to measure medication adherence feasibly. Self-report
is the most frequently used method to assess medication adherence clinically because it is
simple, inexpensive, feasible, and may provide a gross indicator of adherence (Morisky,
Ang, Krousel-Wood, & Ward, 2008; Morisky, Green, & Levine, 1986).
One author (JRW) of this paper previously reported that a one-item self-reported measure of
adherence did not predict clinical outcomes in 134 patients with HF (Wu, et al., 2008). In
that study (Wu, et al., 2008), patients were asked to rate “how often did you take medication
as prescribed (on time without skipping doses) in the past four weeks?” on a scale from 0
(none of the time) to 5 (all of the time). Patients who self-reported taking medication as
prescribed “all of the time” and “most of the time” were categorized as adherent, and those
who reported “a good bit of the time”, “some of the time”, “a little of the time”, and “none
of the time” were categorized as non-adherent. The findings between these 2 self-reported
studies most likely differ because of the different self-report instruments used. In our current
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study, we asked participants to recall their medication taking behavior over the past 7 days
rather than over the past 4 weeks. Cognitive deficits and memory impairment are common in
older people with many other chronic conditions, as well as HF (Bennett & Sauve, 2003;
Bennett, Sauve, & Shaw, 2005; Harkness, Demers, Heckman, & McKelvie, 2011; Pressler et
al., 2010; Sloan & Pressler, 2009). Recalling whether they missed taking their medications
over the past 7 days is easier than recalling whether they missed taking their medications
over the past 4 weeks for elderly participants with HF. This suggests that the self-report
instrument used in this study may be a better self-report measure of medication adherence,
but this should be confirmed in future studies.
Voils and colleagues (2012) recently conducted cognitive interviews in 30 hypertensive
patients to develop a new self-reported measure of medication nonadherence. In terms of
recall period, most patients reported “the last 7 days” was more easily and accurately
recalled and a more sensitive reflection of their medication adherence. This data further
supports our use of the “past 7 days” recall period.
Voils and colleagues 3-item scale (Voils, et al., 2012) assesses the extent of medication
adherence. The 3 items assessed whether individuals “took all doses”, “missed or skipped
doses”, or “were not able to take doses of their medications” over the past 7 days, using 4
response options. The 3-item scale had evidence for reliability and validity and may reduce
measurement error in patients with hypertension. However, our single item measure may be
more feasible for clinical use, and also appears to have good predictive validity. Neither
measure has been compared or validated with other objective measures, such as pill count,
pharmacy refill record, or electronic monitoring. Future studies are needed to examine both
the single item measure and the Voils 3-item scale in a range of conditions and patient
populations.
The mechanisms by which reported adherence influences outcomes are complex. Patients
with high adherence may differ from those with lower adherence in multiple ways. In a
randomized controlled trial (Granger, et al., 2005), 7,599 participants with HF were assigned
to either an angiotensin receptor blocker group or a placebo group and were followed for a
median of 38 months on mortality. In Cox regressions, participants with good adherence had
lower all-cause mortality compared with those with low adherence, even in the placebo
group. The investigators suggested that adherence may be mainly a marker for adherence to
other self-care behaviors (e.g., low sodium diet, exercise, weight monitoring, and follow-up
appointments). In this study, medication adherence was associated with other HF self-care
behaviors. However, when we controlled for self-care behaviors in our model, the effect of
medication adherence on hospitalization and death remained strong, suggesting that
adherence was not simply a marker for other self-care.
There were other differences between participants who were fully adherent and less than
fully adherent in this study, such as age, ethnicity, socioeconomic status, insurance, history
of hypertension or chronic kidney disease, depression, and self-efficacy. When these factors
were entered into the model, participants with full adherence still had reduced incidence of
all-cause and HF-related hospitalizations or mortality, suggesting that the observed
relationship between adherence and outcomes was not simply a result of confounding;
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however, we cannot rule out the possibility of unmeasured confounding in this type of
observational cohort study.
Our study has several other limitations. First, medication adherence was measured only by
self-report method and only at baseline. Use of both objective and self-report measures may
increase accuracy of assessment (Cassidy, Rabinovitch, Schmitz, Joober, & Malla, 2010;
Liu et al., 2001). Our data, which demonstrates a strong relationship between adherence and
outcomes, suggests that adherence was accurately reflected by the self-report measure in this
study. Second, our findings are from only one study; thus, we need additional studies to test
its validity. Third, we did not collect some clinical data that might have an impact on
hospitalizations or death, such as serum sodium, B-type Natriuretic Peptide, or diuretic dose.
However, this analysis was undertaken to examine the specific relationship between self-
reported adherence and HF outcomes, not to be a general analysis of prognostic factors in
HF. Fourth, although we included HF symptoms to represent disease severity in the
statistical analysis, we acknowledge that patients with HF might have other concurrent
conditions that impact health outcomes that were not collected and controlled in our study.
Finally, even though we collected outcome data from patient/family interview and requested
for admission and discharge summaries from all hospitals in which the patient reported
having had a hospital admission for all the full study period, it is possible that participants
may have not recalled all hospitalized events. However, we have no reason to believe this
recall would be differential between adherence groups.
Conclusion
This study had two important findings: 1) medication adherence is associated with all-cause
and HF-related hospitalization and death in HF; 2) self-reported adherence, a simple one-
item question predicts health outcomes. The finding (if confirmed) provides clinicians with
valuable information regarding how to easily screen patients who might be non-adherent to
medication.
Implications for practice
Based on the results of this study, and of others, we recommend that clinicians consider
assessing patients’ medication adherence on a regular basis at their clinical follow-ups. Our
single-item question may be a clinically feasible method of doing so.
Acknowledgments
The project described was supported by Award Number R01HL081257 from the National Heart, Lung, And Blood
Institute and a supplement to that grant provided under the American Recovery and Reinvestment Act of 2009
(ARRA). The content is solely the responsibility of the authors and does not necessarily represent the official views
of the National Heart, Lung, And Blood Institute or the National Institutes of Health.
Reference
Ackermann RT, Rosenman MB, Downs SM, Holmes AM, Katz BP, Li J, et al. Telephonic case-
finding of major depression in a Medicaid chronic disease management program for diabetes and
heart failure. General Hospital Psychiatry. 2005; 27(5):338–343. [PubMed: 16168794]
Wu et al. Page 9






















Ambardekar AV, Fonarow GC, Hernandez AF, Pan W, Yancy CW, Krantz MJ. Characteristics and in-
hospital outcomes for nonadherent patients with heart failure: findings from Get With The
Guidelines-Heart Failure (GWTG-HF). American Heart Journal. 2009; 158(4):644–652. [PubMed:
19781426]
Annema C, Luttik ML, Jaarsma T. Reasons for readmission in heart failure: Perspectives of patients,
caregivers, cardiologists, and heart failure nurses. Heart & Lung. 2009; 38(5):427–434. [PubMed:
19755193]
Baker DW, Brown J, Chan KS, Dracup KA, Keeler EB. A telephone survey to measure
communication, education, self-management, and health status for patients with heart failure: the
Improving Chronic Illness Care Evaluation (ICICE). Journal of Cardiac Failure. 2005; 11(1):36–42.
[PubMed: 15704062]
Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature.
Journal of Cardiovascular Nursing. 2003; 18(3):219–242. [PubMed: 12837012]
Bennett SJ, Sauve MJ, Shaw RM. A conceptual model of cognitive deficits in chronic heart failure. J
Nurs Scholarsh. 2005; 37(3):222–228. [PubMed: 16235862]
Cassidy CM, Rabinovitch M, Schmitz N, Joober R, Malla A. A comparison study of multiple measures
of adherence to antipsychotic medication in first-episode psychosis. Journal of Clinical
Psychopharmacology. 2010; 30(1):64–67. [PubMed: 20075650]
Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart
failure. American Journal of Public Health. 1997; 87(4):643–648. [PubMed: 9146445]
Chui MA, Deer M, Bennett SJ, Tu W, Oury S, Brater DC, et al. Association between adherence to
diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy. 2003;
23(3):326–332. [PubMed: 12627931]
Cole JA, Norman H, Weatherby LB, Walker AM. Drug copayment and adherence in chronic heart
failure: effect on cost and outcomes. Pharmacotherapy. 2006; 26(8):1157–1164. [PubMed:
16863491]
DeWalt DA, Broucksou KA, Hawk V, Baker DW, Schillinger D, Ruo B, et al. Comparison of a one-
time educational intervention to a teach-to-goal educational intervention for self-management of
heart failure: design of a randomized controlled trial. BMC Health Serv Res. 2009; 9:99.
[PubMed: 19519904]
Dewalt DA, Schillinger D, Ruo B, Bibbins-Domingo K, Baker DW, Holmes GM, et al. Multisite
randomized trial of a single-session versus multisession literacysensitive self-care intervention for
patients with heart failure. Circulation. 2012; 125(23):2854–2862. [PubMed: 22572916]
Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS. Medicaid beneficiaries with congestive
heart failure: association of medication adherence with healthcare use and costs. American Journal
of Managed Care. 2009; 15(7):437–445. [PubMed: 19589011]
Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, et al. Risk stratification
after hospitalization for decompensated heart failure. Journal of Cardiac Failure. 2004; 10(6):460–
466. [PubMed: 15599835]
Gazmararian JA, Baker DW, Williams MV, Parker RM, Scott TL, Green DC, et al. Health literacy
among Medicare enrollees in a managed care organization. Jama. 1999; 281(6):545–551.
[PubMed: 10022111]
Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors associated with medication
refill adherence in cardiovascular-related diseases: a focus on health literacy. Journal of General
Internal Medicine. 2006; 21(12):1215–1221. [PubMed: 17105519]
Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart
failure. Traits among urban blacks. Archives of Internal Medicine. 1988; 148(9):2013–2016.
[PubMed: 3046541]
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke
statistics--2013 update: a report from the american heart association. Circulation. 2013; 127(1):e6–
e245. [PubMed: 23239837]
Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, et al. Adherence to
candesartan and placebo and outcomes in chronic heart failure in the CHARM programme:
Wu et al. Page 10






















Double-blind, randomised, controlled clinical trial. Lancet. 2005; 366(9502):2005–2011.
[PubMed: 16338449]
Hamner JB, Ellison KJ. Predictors of hospital readmission after discharge in patients with congestive
heart failure. Heart & Lung. 2005; 34(4):231–239. [PubMed: 16027642]
Harkness K, Demers C, Heckman GA, McKelvie RS. Screening for cognitive deficits using the
Montreal cognitive assessment tool in outpatients >/=65 years of age with heart failure. American
Journal of Cardiology. 2011; 107(8):1203–1207. [PubMed: 21310371]
Hauptman PJ. Medication adherence in heart failure. Heart Fail Rev. 2008; 13(1):99–106. [PubMed:
17479364]
Hodges P. Heart failure: epidemiologic update. Critical Care Nursing Quarterly. 2009; 32(1):24–32.
[PubMed: 19077806]
Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and
skills with emergency department visits by adults 50 years or older with congestive heart failure.
American Journal of Health-System Pharmacy. 2004; 61(19):2043–2049. [PubMed: 15509127]
Kalichman SC, Pope H, White D, Cherry C, Amaral CM, Swetzes C, et al. Association between health
literacy and HIV treatment adherence: further evidence from objectively measured medication
adherence. J Int Assoc Physicians AIDS Care (Chic Ill). 2008; 7(6):317–323.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure.
Journal of General Internal Medicine. 2001; 16(9):606–613. [PubMed: 11556941]
Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI. Predictors of readmission
among elderly survivors of admission with heart failure. American Heart Journal. 2000; 139(1 Pt
1):72–77. [PubMed: 10618565]
Li H, Morrow-Howell N, Proctor EK. Post-acute home care and hospital readmission of elderly
patients with congestive heart failure. Health & Social Work. 2004; 29(4):275–285. [PubMed:
15575455]
Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple
measures of adherence to HIV protease inhibitors. Annals of Internal Medicine. 2001; 134(10):
968–977. [PubMed: 11352698]
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and
stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;
121(7):e46–e215. [PubMed: 20019324]
Macabasco-O'Connell A, Dewalt DA, Broucksou KA, Hawk V, Baker DW, Schillinger D, et al.
Relationship Between Literacy, Knowledge, Self-Care Behaviors, and Heart Failure-Related
Quality of Life Among Patients With Heart Failure. Journal of General Internal Medicine. 2011
Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y. Effect of digoxin noncompliance on
hospitalization and mortality in patients with heart failure in long-term therapy: A prospective
cohort study. European Journal of Clinical Pharmacology. 2001; 57(1):77–83. [PubMed:
11372597]
Morgan AL, Masoudi FA, Havranek EP, Jones PG, Peterson PN, Krumholz HM, et al. Difficulty
taking medications, depression, and health status in heart failure patients. Journal of Cardiac
Failure. 2006; 12(1):54–60. [PubMed: 16500581]
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence
measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348–354. [PubMed:
18453793]
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of
medication adherence. Medical Care. 1986; 24(1):67–74. [PubMed: 3945130]
Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of
heart failure include treatment adherence and health literacy skills. Clinical Pharmacology and
Therapeutics. 2009; 85(6):651–658. [PubMed: 19262464]
Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, et al. Pharmacist intervention to improve
medication adherence in heart failure: a randomized trial. Annals of Internal Medicine. 2007;
146(10):714–725. [PubMed: 17502632]
Wu et al. Page 11






















Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and
cardiovascular disease outcomes in the Second Australian National Blood Pressure Study
(ANBP2). Medical Journal of Australia. 2006; 185(9):487–489. [PubMed: 17137452]
O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical
characteristics, and outcomes of patients hospitalized for decompensated heart failure:
observations from the IMPACT-HF registry. Journal of Cardiac Failure. 2005; 11(3):200–205.
[PubMed: 15812748]
Opasich C, Febo O, Riccardi PG, Traversi E, Forni G, Pinna G, et al. Concomitant factors of
decompensation in chronic heart failure. American Journal of Cardiology. 1996; 78(3):354–357.
[PubMed: 8759821]
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of
candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall
programme. Lancet. 2003; 362(9386):759–766. [PubMed: 13678868]
Pressler SJ, Subramanian U, Kareken D, Perkins SM, Gradus-Pizlo I, Sauve MJ, et al. Cognitive
deficits in chronic heart failure. Nursing Research. 2010; 59(2):127–139. [PubMed: 20216015]
Riegel B, Moser DK, Anker SD, Appel LJ, Dunbar SB, Grady KL, et al. State of the science:
promoting self-care in persons with heart failure: a scientific statement from the American Heart
Association. Circulation. 2009; 120(12):1141–1163. [PubMed: 19720935]
Sloan RS, Pressler SJ. Cognitive deficits in heart failure: Re-cognition of vulnerability as a strange
new world. Journal of Cardiovascular Nursing. 2009; 24(3):241–248. [PubMed: 19390342]
Smith DM, Giobbie-Hurder A, Weinberger M, Oddone EZ, Henderson WG, Asch DA, et al.
Predicting non-elective hospital readmissions: A multi-site study. Department of Veterans Affairs
Cooperative Study Group on Primary Care and Readmissions. Journal of Clinical Epidemiology.
2000; 53(11):1113–1118. [PubMed: 11106884]
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on
hospitalization risk and healthcare cost. Medical Care. 2005; 43(6):521–530. [PubMed: 15908846]
Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in
hospitalization for heart failure in Scotland 1990–1996. An epidemic that has reached its peak?
European Heart Journal. 2001; 22(3):209–217. [PubMed: 11161932]
Sun SX, Ye X, Lee KY, Dupclay L Jr, Plauschinat C. Retrospective claims database analysis to
determine relationship between renin-angiotensin system agents, rehospitalization, and health care
costs in patients with heart failure or myocardial infarction. Clinical Therapeutics. 2008; 30(Pt 2):
2217–2227. [PubMed: 19281916]
Voils CI, Maciejewski ML, Hoyle RH, Reeve BB, Gallagher P, Bryson CL, et al. Initial validation of a
self-report measure of the extent of and reasons for medication nonadherence. Medical Care. 2012;
50(12):1013–1019. [PubMed: 22922431]
Wu JR, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication
adherence independently predicts event-free survival in patients with heart failure. Journal of
Cardiac Failure. 2008; 14(3):203–210. [PubMed: 18381183]
Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure:
a review of the literature. Nursing Clinics of North America. 2008; 43(1):133–153. [PubMed:
18249229]
Wu et al. Page 12






















What does this paper contribute to the wider global clinical community?
• Medication adherence is associated with all-cause and HF-related
hospitalization and death in HF.
• Self-reported adherence, a simple one-item question predicts health outcomes.
• It is important for clinicians to assess patients’ medication adherence on a
regular basis at their clinical follow-ups.
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Table 1








Size 592 163 (28) 429 (72)
Demographics
Site P=0.039
   UNC 208 (35) 45 (28) 163 (38)
   NU 162 (27) 56 (34) 106 (25)
   UCSF 148 (25) 44 (27) 104 (24)
   UCLA 74 (13) 18 (11) 56 (13)
TOFHLA: Adequate 375 (63) 113 (69) 262 (61) P=0.063
Age 60.6±13.1 56.7±12.7 62.1±12.9 P<0.001
Race/Ethnicity P=0.064
   White NH 226 (38) 51 (31) 175 (41)
   Hispanic 96 (16) 23 (14) 73 (17)
   African American 230 (39) 78 (48) 152 (35)
   Other 40 (7) 11 (7) 29 (7)
Gender: Male 308 (52) 88 (54) 220 (51) P=0.556
Language: English 510 (86) 146 (90) 364 (85) P=0.137
Income Level, $ P=0.819
   <15,000 300 (51) 82 (50) 218 (51)
   15,000–24,999 88 (15) 27 (17) 61 (14)
   25,000–40,000 65 (11) 16 (10) 49 (11)
   >40,000 124 (21) 34 (21) 90 (21)
Education Level P=0.255
   <12th grade 157 (27) 35 (22) 122 (28)
   High School 174 (29) 56 (34) 118 (28)
   Some college 136 (23) 38 (23) 98 (23)
   College graduate or Greater 125 (21) 34 (21) 91 (21)
Subjective Socioeconomic Status 4.77±2.51 4.23±2.37 4.97±2.53 P=0.001
Insurance P<0.001
   Medicaid 149 (25) 48 (29) 101 (24)
   Medicare Only 62 (11) 7 (4) 55 (13)
   Private Only 77 (13) 34 (21) 43 (10)
   Uninsured 77 (13) 28 (17) 49 (11)
   Medicare & Medicaid 101 (17) 24 (15) 77 (18)
   Medicare & Private 126 (21) 22 (14) 104 (24)
Clinical characteristics
HFSS 60.9±22.0 59.4±22.0 61.4±22.0 P=0.316































   I 112 (19) 29 (18) 83 (19)
   II 297 (50) 83 (51) 214 (50)
   III 117 (20) 34 (21) 83 (19)
   IV 66 (11) 17 (10) 49 (11)
Systolic Dysfunction: Ejection fraction <0.45 346 (58) 95 (58) 251 (59) P=0.960
Systolic BP (mm/Hg) 125±22.7 125±25.0 125±21.8 P=0.944
Diastolic BP (mm/Hg) 71.3±12.9 73.1±14.1 70.6±12.4 P=0.041
Body Mass index 33.2±8.86 33.6±8.77 33.1±8.89 P=0.574
Creatinine level 1.26±0.548 1.21±0.521 1.28±0.558 P=0.191
Diabetes 284 (48) 76 (47) 208 (49) P=0.686
Hypertension 502 (85) 129 (79) 373 (87) P=0.018
Atrial Fibrillation 282 (48) 70 (43) 212 (49) P=0.159
Previous MI or angina 241 (41) 57 (35) 184 (43) P=0.080
Chronic Kidney Disease 247 (42) 55 (34) 192 (45) P=0.015
Depressed PHQ>=10 193 (33) 69 (42) 124 (29) P=0.002
Current smoker 95 (16) 37 (23) 58 (14) P=0.007
Medication History
   ACE-I 383 (65) 111 (68) 272 (63) P=0.286
   ARB 118 (20) 29 (18) 89 (21) P=0.422
   ACE-I or ARB 487 (82) 136 (83) 351 (82) P=0.645
   Beta blocker 482 (81) 136 (83) 346 (81) P=0.437
Intervention status 298 (50) 88 (54) 210 (49%) P=0.274
Knowledge and behavioral factors
HF general knowledge 6.16±1.75 6.02±1.74 6.21±1.76 P=0.230
Salt knowledge 7.55±1.52 7.50±1.68 7.56±1.46 P=0.631
Self-efficacy 78.3±14.4 74.1±16.3 79.9±13.3 P<0.001
Self-care behaviors 4.61±2.04 3.99±1.94 4.85±2.03 P<0.001
ACE-I = Angiotensin Converting Enzyme Inhibitor; ARB = Angiotensin Receptor Blocker; HF = heart failure; HFSS = Heart Failure Symptom
Scale; NYHA = New York Heart Association functional classification; PHQ = Patient Health Questionnaire; TOFHLA = Test of Functional Health
Literacy in Adults.
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